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Abstract 11 
Riboswitches are conserved regions within mRNA molecules that bind specific metabolites and 12 
regulate gene expression. TPP-riboswitches, which respond to thiamine pyrophosphate (TPP), are 13 
involved in the regulation of thiamine metabolism in numerous bacteria. As these regulatory 14 
RNAs are often modulating essential biosynthesis pathways they have become increasingly 15 
interesting as promising antibacterial targets. Here, we describe thiamine analogs containing a 16 
central 1,2,3-triazole group to induce repression of thiM-riboswitch dependent gene expression in 17 
different E. coli strains. Additionally, we show that compound activation is dependent on proteins 18 
involved in the metabolic pathways of thiamine uptake and synthesis. The most promising 19 
molecule, triazolethiamine (TT), shows concentration dependent reporter gene repression that is 20 
dependent on the presence of thiamine kinase ThiK, whereas the effect of pyrithiamine (PT), a 21 
known TPP-riboswitch modulator, is ThiK independent. We further show that this dependence 22 
can be bypassed by triazolethiamine-derivatives that bear phosphate-mimicking moieties. As 23 
triazolethiamine reveals superior activity compared to pyrithiamine, it represents a very promising 24 
starting point for developing novel antibacterial compounds that target TPP-riboswitches. 25 
Riboswitch-targeting compounds engage diverse endogenous mechanisms to attain in vivo 26 
activity. These findings are of importance for the understanding of compounds that require 27 
metabolic activation to achieve effective riboswitch modulation and they enable the design of 28 
novel compound generations that are independent of endogenous activation mechanisms.  29 
 30 
  31 
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Introduction 32 
Riboswitches are RNA elements mostly found in the 5Õ UTR of bacterial mRNA that specifically 33 
sense the concentration of a small metabolite. Upon metabolite binding, substantial 34 
conformational changes occur that ultimately result in an on- or off-switch of gene expression. 35 
These regulatory elements represent a fundamental new means of controlling cellular processes in 36 
response to environmental conditions (Breaker 2011). Riboswitches often regulate expression of 37 
essential genes and as such they are interesting target structures for the development of novel 38 
antibiotic compounds (Blount and Breaker 2006). Artificial compounds acting successfully on 39 
riboswitches have to meet at least two criteria: i) they must specifically bind to the relevant RNA 40 
structure and ii) induce the conformational changes that finally lead to down- or up-regulation of 41 
gene expression. In recent years synthetic molecules that meet these criteria have been discovered 42 
for several riboswitch classes (Lnse, Schller et al. 2014).  One of them is the TPP-riboswitch 43 
(Miranda-Rios, Navarro et al. 2001; Winkler, Nahvi et al. 2002), which selectively interacts with 44 
thiamine pyrophosphate (TPP) by binding to its pyrimidine moiety through the so-called 45 
pyrimidine sensor helix (P2, J2-3, P3) of the aptamer domain. Conformational changes of the 46 
riboswitch resulting in repression of gene expression are only achieved if the pyrophosphate 47 
group of the ligand is recognized by the pyrophosphate sensor helix (P4, J4-5, P5, Figure 1A) 48 
(Edwards and Ferre-D'Amare 2006; Serganov, Polonskaia et al. 2006; Thore, Leibundgut et al. 49 
2006). While this riboswitch class has been shown to allow a greater degree of variation at the 50 
position of the thiazole ring, exemplified by the thiamine analog pyrithiamine (PT, Figure 2A), 51 
the presence of the pyrophosphate moiety is mandatory to interact with and, more importantly, to 52 
induce switching of the E. coli thiM-riboswitch (Winkler, Nahvi et al. 2002; Rentmeister, Mayer 53 
et al. 2007). This necessity impedes the development of compounds that act on TPP-riboswitches, 54 
since either they cannot passively pass the cell wall due to the highly charged pyrophosphate 55 
moiety or they cannot efficiently activate the riboswitch if lacking this group. PTÕs in vivo 56 
activity most likely relies on hijacking endogenous metabolic enzymes that phosphorylate 57 
exogenously added PT, thereby yielding the active derivative pyrithiamine pyrophosphate (PTPP) 58 
(Iwashima, Wakabayashi et al. 1976). In this report we elaborate on a series of triazolethiamines 59 
(TT) that have been shown recently to act on TPP-riboswitches in vitro, if diphosphorylated 60 
yielding triazolethiamine pyrophosphate (TTPP). We investigated TT-activity in relation to the 61 
length and modification of the alkyl chain and the presence of endogenous proteins involved in 62 
thiamine metabolism. We found that the activity of triazolethiamine (TT) depends on the 63 
metabolic enzyme thiamine kinase (ThiK) and thiamine transporters. Most importantly, we 64 
demonstrated that ThiK dependency is bypassed by triazolethiamine-derivatives that bear 65 
phosphate mimicking and metal-ion chelating moieties. This strategy opens new avenues towards 66 
riboswitch activating compounds, in particular those that rely on phosphate groups to recognize 67 
and switch cognate RNA structures.  68 
 69 
Materials and methods 70 
β-Galactosidase reporter gene assay 71 
For β-galactosidase assays 5 ml pre-cultures of DH5αZ1, BW25113 or Keio deletion strains 72 
containing the appropriate plasmid constructs were prepared in LB Lennox standard medium 73 
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(lysogeny broth Lennox, 10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl in water) and incubated 74 
over night at 37¡C and 155 rpm. Incubation was followed by photometric measurement of optical 75 
density at λ= 600 nm (OD600) and dilution of cells to an optical density of 0.5. This dilution was 76 
used to inoculate β-galactosidase expression cultures at a ratio of 1:500 in a final volume of 2 or 4 77 
ml in M9 medium (5x M9 medium containing 15 g/l KH2PO4, 5 g/l NH4Cl, 2.5 g/l NaCl, 30 g/l 78 
Na2HPO4) containing final concentrations of 5 mM MgSO4, 0.2 wt% glucose, 0.2 µg/µl casamino 79 
acids (Difco), and 100µg/ml ampicillin. Even though vitamin-deprived casamino acids were used, 80 
growth of thiamine auxotrophic strains was observed without addition of thiamine indicating that 81 
a small, but constant amount of thiamine must be present in the casamino acid stock. Minimal 82 
inhibitory concentration determinations in casamino acid free minimal medium with separately 83 
added amino acids revealed that at least 1 nM of thiamine is necessary to enable bacterial growth 84 
of the thiamine auxotrophs investigated. The expression cultures contained either 20 or 500 µM 85 
of thiamine (Sigma), 500 µM pyrithiamine (Sigma) or 500µM of the compounds, respectively. 86 
Controls received neither thiamine, or pyrithiamine nor compounds. If compounds had to be 87 
dissolved in DMSO, controls were supplemented with equal amounts (final DMSO concentration: 88 
1%). The cultures were incubated for 24 h at 37¡C and 150 rpm. After 24 h incubation the optical 89 
density was measured. The cells were centrifuged at 4500 g for 5 min and the pellets were washed 90 
twice in 400 µl 1x PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4x2H2O, 2 mM KH2PO4, 91 
pH 7.4). The pellets were resuspended in 200 µl 1x lysis buffer (Reporter Lysis Buffer, Promega), 92 
incubated for 15 min at room temperature and cells were pelleted. Supernatants were used for all 93 
following steps. 75 µl of the respective lysates were mixed with 75 µl of 2x assay buffer (200 94 
mM sodium phosphate buffer pH 7.3, 2 mM MgCl2, 100 mM β-mercaptoethanol, 1.33 mg/ml 95 
ONPG) and incubated for 5-15 min at 37¡C. The reaction was stopped by the addition of 250µl 1 96 
M Na2CO3 and absorbance at 420 nm was measured immediately using a Nanoquant (Infinite 97 
200, Tecan). Reporter gene assays were performed in clear, flat bottom 96-well plates. Miller 98 
units were calculated according to the following formula: Miller units = (1000*OD420)/(OD 99 
600*incubation time [min]*culture volume [L]) and Miller units of controls without thiamine or 100 
compound added were set to 1. Samples were run in duplicate and experiments were repeated at 101 
least three times. 102 
 103 
Results 104 
Thiamine analogs that bear a 1,2,3-triazole group instead of the thiazole heterocyclic moiety as 105 
found in thiamine were synthesized and investigated for TPP-riboswitch activation using a β-106 
galactosidase reporter gene assay (Figure 1B). In this assay the TPP-riboswitch thiM from E. coli 107 
was cloned into the 5«-UTR of β-galactosidase. The DH5αZ1 E. coli strain was transformed by 108 
this plasmid (Simons, Houman et al. 1987; Diederich, Rasmussen et al. 1992; Lutz and Bujard 109 
1997). Due to the thi-1 mutation, DH5αZ1 cells are thiamine auxotroph, which means they are 110 
dependent on thiamine uptake from the growth medium (Supplementary Table 1). This enables 111 
direct external control of the availability of this vitamin. Synthesis of TT-compounds was 112 
achieved using a ÔclickÕ chemistry approach utilizing a common azide intermediate, which was 113 
then further reacted with the appropriate substituted alkyne yielding corresponding thiamine 114 
analogs (Figure 2A, Supplementary Figure 1). Subsequent monitoring of β-galactosidase activity 115 
was performed in the presence and absence of thiamine or triazolethiamine (TT) derivatives. 116 
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Addition of thiamine to the E. coli cultures resulted in a complete loss of β-galactosidase 117 
expression; an IC50-value of 0.015 µM was observed (Figure 2 and Table 1). In line with previous 118 
findings, pyrithiamine (PT) was shown incapable of β-galactosidase repression in DH5αZ1 119 
(Figure 2B)(Sudarsan, Cohen-Chalamish et al. 2005). On the other hand, the addition of 500µM 120 
TT (1) represses the expression of βÐgalactosidase expression to a level similar to that of 121 
thiamine. TT has been shown to depend on diphosphorylation to gain activity in vitro (Chen, 122 
Cressina et al. 2012). Thus, we anticipate that TT is phosphorylated by the endogenous set of 123 
thiamine converting enzymes. Shortening (2) or elongating the alkyl side chain (3 and 4, Figure 124 
1a) results in a loss of repression with increasing deviation from the natural alkyl chain length 125 
(Figure 1B). This is most likely due to reduced uptake and/or phosphorylation of these 126 
compounds, but could also be because of a poor fit of phosphorylated triazolethiamines to the 127 
riboswitch. Previously, it has been shown that the thi-box aptamer domain is somewhat adjustable 128 
to ligand size through compaction of pyrimidine and phosphate sensor helices (Edwards and 129 
Ferre-D'Amare 2006). However, this low affinity ligand binding (thiamine KD= 50µM vs. TPP 130 
KD= 50nM, (Sudarsan, Cohen-Chalamish et al. 2005)) is unlikely to efficiently induce subsequent 131 
changes in the expression platform (Serganov, Polonskaia et al. 2006) and thus reporter gene 132 
expression. Interestingly, compound 5, which bears an amino group instead of a hydroxyl residue 133 
on the ethyl-alkyl side chain of TT, also represses reporter gene activity. How this compound 134 
would be activated through in vivo phosphorylation is unclear. However, it is possible that 5 is 135 
also phosphorylated in the same way as TT. Experiments using a mutant version of the thiM 136 
riboswitch (thiM-Mu, Figure 1A), which is incapable of binding to TPP showed that neither of the 137 
investigated TT-compounds represses gene expression in these assays. These data underline that 138 
repression of gene expression truly relies on riboswitch binding and activation. We next measured 139 
IC50-values of these compounds, to evaluate concentration dependent repression of gene 140 
expression.  TT (1) revealed the strongest effect with an IC50-value of 8.4 µM (Table 1 and 141 
Supplementary Figure 2). Compounds with increasing alkyl-chain length (3 and 4) showed no 142 
concentration dependent inhibition curves (Table 1) and, as expected for this bacterial strain, PT 143 
did not show an effect on β-galactosidase expression (Table 1, Figure 2A). In order to investigate 144 
the dependence of TT activity on endogenous proteins and enzymes involved in thiamine 145 
biosynthesis, several strains of the Keio collection were investigated, that all originate from the 146 
strain BW25113, and contain deletions of non-essential genes known to be involved in thiamine 147 
metabolism of E. coli (Scheme 1) (Baba, Ara et al. 2006).  148 
Thiamine is synthesized from two precursors, hydroxymethylpyrimidine diphosphate (HMP-PP) 149 
and hydroxyethylthiazole phosphate (HET-P), which are produced independently and finally 150 
joined to form thiamine phosphate (Begley, Downs et al. 1999). Further phosphorylation yields 151 
the cofactor TPP (Scheme 1). The Keio deletion strains were transformed with the β-152 
galactosidase reporter plasmid containing either the wild type or the mutant TPP-riboswitch and 153 
effects of thiamine, TT or PT on reporter gene expression were assayed (Table 2, Figure 3, 154 
Supplementary Figures 9 and 10). In most strains the addition of thiamine led to a strong decrease 155 
in β-galactosidase expression that is comparable to that observed for the wild type strain. As 156 
expected, the thiK deletion strain (ΔthiK) revealed decreased thiamine sensitivity, since this 157 
enzyme is required for the phosphorylation of thiamine to TPP. When adding thiamine, thiI and 158 
iscS deletion strains showed slightly increased levels of reporter gene expression indicating a loss 159 
of TPP-riboswitch activation (Figure 3A). Investigating the impact of TT (Figure 3B) on TPP-160 
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riboswitch dependent reporter gene expression in the deletion strains revealed a prominent 161 
increase in reporter gene expression for those strains containing deletions of thiamine transport 162 
genes (Scheme 2; thiP, thiQ, tbpA) in comparison to wild type cells (Figure 3B, magenta bars). 163 
This may indicate that TT uptake is, at least in part, mediated by these ABC-transporters. 164 
However in the presence of PT, reporter gene expression in these strains was scarcely increased 165 
in comparison to the wild type strain (Figure 3C). This suggests that PT, just like thiamine 166 
(Figure 3A), must use other routes of cell entry apart from the thiamine-specific active 167 
transporter. Possibly, its positive charge supports passive diffusion processes, as believed to occur 168 
for thiamine as well (Webb, Claas et al. 1998). Besides the dependence on transport proteins, 169 
differential effects on several other deletion strains involved in phosphate-transfer or thiazole 170 
formation were observed (Figure 3, green and gray bars, respectively). Assaying ΔthiK, ΔthiD and 171 
ΔthiM, strains, whose deleted genes are involved in phosphate transfer reactions, revealed 172 
increased β-galactosidase expression in the presence of TT compared to wild type, whereas ΔthiE 173 
showed decreased β-galactosidase expression (Figure 3B). As the deletion of thiE renders the 174 
bacteria incapable of synthesizing any TPP from its HMP and HET precursors (Scheme 1), the 175 
reporter gene expression is mainly influenced by external thiamine or compound supply. 176 
Interestingly, the prominent decrease of β-galactosidase expression in the presence of TT is 177 
comparable to that found for thiamine at the same concentration in the wild type strain BW25113 178 
(Figure 3A, black bars). In ΔthiE cells, lower intracellular concentrations of thiamine compete for 179 
any possible enzymatic TT-activation mechanism (such as phosphorylation or take-up). 180 
Therefore, the same amounts of TT lead to a stronger decrease of reporter gene expression in 181 
these cells in comparison to other deletion strains (Figure 3B). In the presence of TT, thiC and 182 
iscS deletion strains which are involved in formation of the thiazole moiety of thiamine revealed 183 
increased β-galactosidase expression (Figure 3B). At the same time β-galactosidase expression in 184 
thiI, thiG, thiH and sufS deletion strains remained unaffected or was slightly decreased in the 185 
presence of PT (Figure 3C). Finally, PT-treated E. coli strains containing deletions of the genes 186 
thiD and thiC, which are involved in the biosynthesis of the pyrimidine-containing precursor 187 
HMP-PP (Scheme 1), show an increase in reporter gene expression (Figure 3C). The same is 188 
observed for the ΔthiE strain. The deletion of iscS renders bacteria less susceptible to thiamine, 189 
TT or PT (Supplementary Figure 3). However, it should be noted that the ΔiscS strain showed 190 
slower growth than any of the other deletion strains investigated. This reduced fitness may be due 191 
to the fact that ThiI and IscS are not only involved in thiamine metabolism but also needed in the 192 
4-thiouridine biosynthetic pathway (Scheme 1). Interestingly, deleting the thiamine kinase ThiK 193 
abolished thiamine and TT dependent inhibition of reporter gene expression (Figure 3A and 3B). 194 
This finding underlines the hypothesis that TT is only active in vivo in its phosphorylated form. 195 
Due to its close structural similarity to the natural substrate thiamine, TT is likely to be 196 
recognized and phosphorylated by endogenous bacterial enzymes such as ThiK. Using ITC 197 
measurements Chen and colleagues revealed that the chemically synthesized, diphosphorylated 198 
form of TT, named triazolethiamine pyrophosphate (TTPP), binds to the thiM riboswitch with an 199 
affinity of 370 nM, whereas for the natural ligand TPP a KD of 8 nM was measured (Chen, 200 
Cressina et al. 2012). Additionally, in vitro translation assays proved that binding of TTPP 201 
induces a change in riboswitch secondary structure to sequester the SD-sequence and inhibits 202 
efficient protein translation (Chen, Cressina et al. 2012). Therefore, endogenous 203 
diphosphorylation of TT would generate a very potent TPP-riboswitch activator. Hence, we were 204 
intrigued to find that reporter gene expression for the thiK deletion strain is dramatically 205 
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decreased in the presence of PT (Figure 3C). This suggests that PT either does not need to be 206 
activated by pyrophosphorylation through ThiK, that it can also be phosphorylated by other 207 
endogenous enzymes like ThiE or that it is converted into TPP through salvage pathways. 208 
In order to bypass ThiK-dependency of TT activity in E. coli, triazolethiamine derivatives that 209 
were intended to be independent of endogenous phosphorylation were synthesized and their 210 
impact on riboswitch regulation of β-galactosidase expression was studied. These compounds 211 
contain a number of phosphate mimics (sulfate, sulfonamide, and sulfone) and metal-chelating 212 
groups (dicarbonyl compounds) that might be expected to interact with phosphate-binding metal 213 
ions in proteins (Supplementary Figures 4-8). A ÔclickÕ chemistry approach was used to generate 214 
sulfone 7 and the methotrexate- or folate- like compounds 15 and 16. Amide couplings were 215 
performed to obtain the sulfonamides 8 and 9 and also to obtain the pyruvate, malonate and 216 
salicylic acid containing compounds 10, 11 and 12, respectively (Erixon, Dabalos et al. 2008). 217 
Additionally, a Michael addition was used to generate the sulfones 13 and 14.   218 
With respect to the phosphate mimics, the sulfonamide 13 and the sulfone 14 that are connected 219 
to a benzyl group scarcely activate the thiM riboswitch in DH5αZ1 cells. The sulfonamide 8 had a 220 
similar effect on β-galactosidase expression in the thiamine auxotroph strain. Interestingly, 221 
compounds containing the planar benzene ring are not as active in thiM riboswitch activation, 222 
even though it is imaginable that this aromatic ring could tighten compound-riboswitch 223 
interaction by π-π-stacking with RNA nucleobases (Edwards and Ferre-D'Amare 2006; Thore, 224 
Leibundgut et al. 2006). Compounds 15 and 16 were found to be the most potent repressors of 225 
reporter gene expression (Figure 4B, ~0.5 fold β-galactosidase expression). Compounds of this 226 
group have enough flexibility in principle to interact with two metal ions via their ester or 227 
carboxyl groups. Interestingly, these molecules activate the thiM riboswitch extensively, despite 228 
their relatively large size. The carboxylate ethyl esters like 15 are likely to enter the cell passively 229 
and are probably hydrolyzed by esterases resulting in 16. To investigate whether the most potent 230 
phosphate mimics exhibit a ThiK independent reduction in reporter gene expression, compounds 231 
7 and 16 were chosen and assayed in the thiamine kinase deficient E. coli strain (Figure 5A). In 232 
contrast to addition of thiamine or TT, which do not reduce reporter gene expression, the addition 233 
of the same amount of 7 and 16 induces a decrease of β-galactosidase expression to 234 
approximately 0.25 fold (Figure 5A). However, ΔthiK strains transformed by the mutated thiM 235 
riboswitch construct do not or only slightly respond to thiamine or compound addition 236 
(Supplementary Figure 11A). In wild type E. coli strain BW25113 thiamine has the strongest 237 
influence on β-galactosidase repression. TT and compound 7 are almost as efficient in inhibiting 238 
gene expression whereas PT and compound 16 show somewhat weaker effects (Figure 5B). 239 
Again no significant influence on reporter gene expression in cells containing the mutant thiM 240 
riboswitch was observed (Supplementary Figure 11C). Investigating the deletion of one subunit 241 
of the active thiamine transporter (ThiP) revealed increased levels of reporter protein for TT, 7 242 
and 16, indicating that these molecules are at least in part taken-up via this mechanism (Figure 243 
5C). The investigation of the mutant riboswitch construct thiM-Mu proves these compound 244 
effects to be specific for thiM riboswitch activation, as the mutated RNA does not alter protein 245 
expression (Supplementary Figure 11). 246 
Discussion 247 
TPP-box riboswitches are interesting and attractive target structures for developing antibacterial 248 
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compounds. They form the most extensive riboswitch class with representatives found in bacteria, 249 
archea and plants (Kubodera, Watanabe et al. 2003; Sudarsan, Barrick et al. 2003; Bocobza, 250 
Adato et al. 2007). Here we show that replacing the thiazole heterocycle with 1,2,3-triazole is a 251 
valuable strategy to generate thiamine analogs that interact with TPP-box riboswitches and, thus, 252 
induce repression of gene expression. These findings are in line with the observations of Chen al. 253 
recently reporting that the diphosphorylated triazolethiamine indeed interacts with the thiM 254 
riboswitch in vitro, albeit with decreased affinity (Chen, Cressina et al. 2012). We went a 255 
significant step further and demonstrated that these compounds are effective in E. coli and, more 256 
importantly, that their activity depends on proteins involved in the metabolic pathways of 257 
thiamine uptake and synthesis.  258 
The data shown above indicate that activity of TT depends on active uptake and endogenous 259 
phosphorylation by ThiK. Surprisingly, PT was found to be independent of ThiK and 260 
transporters. Therefore, PT is either phosphorylated by other kinases apart from ThiK or its 261 
phosphorylation, against all previous hypotheses, is not necessary for in vivo activity (Edwards 262 
and Ferre-D'Amare 2006; Deigan Warner 2014). Unphosphorylated PT is known to have a more 263 
than 1000 fold lower affinity for the TPP-riboswitch, whereas diphosphorylation results in a KD 264 
that is only 3fold higher than that of TPP (Sudarsan, Cohen-Chalamish et al. 2005). Although PT 265 
was shown to bind to the pyrimidine sensor helix of the aptamer domain by one hydrogen bond 266 
and the stacking of the aminopyrimidine ring, crystal structures revealed that two hydrogen bonds 267 
have been lost in comparison to TMP or TPP interactions. The pyrophosphate sensor helix is 268 
largely disordered and it is questionable whether this riboswitch conformation allows gene 269 
regulation upon PT binding (Edwards and Ferre-D'Amare 2006). Furthermore, the increase in 270 
thiM-riboswitch dependent reporter gene expression in the presence of PT in ΔthiD or ΔthiC 271 
strains suggests the existence of a PT-detoxification mechanism in E. coli as proposed for B. 272 
subtilis by Sudarsan et al. in 2005 (Sudarsan, Cohen-Chalamish et al. 2005). If indeed there was a 273 
thiaminase-II-like enzyme present in E. coli, HMP could be recovered from PT and used for the 274 
generation of thiamine through combination with de novo synthesized thiazole (Scheme 1). This 275 
PT recycling would lead to a decrease of its intracellular concentration, hence a diminished 276 
influence on the TPP-riboswitch-dependent gene expression. At the same time, the newly 277 
generated TPP is likely to be used immediately for its biological purpose without accumulation 278 
and hence a need for riboswitch-mediated down regulation of gene expression. Even though a 279 
TenA-like protein has not yet been identified in E. coli, in silico predictions indicate that ThiC 280 
may represent a functional equivalent of TenA (Morett, Korbel et al. 2003). 
 
281 
We further show that equipping TT with metal-chelating groups results in ThiK- and transport-282 
independent activity. This indirectly proves that TT requires phosphorylation and indicates a 283 
possible route in riboswitch activator design which circumvents the necessity of endogenous 284 
proteins and renders riboswitch inhibitors independent of bacterial pathways. The most promising 285 
phosphate-mimics were tested for their dependence on ThiK or active thiamine transport 286 
mechanisms. Whereas activity of compound 16 appears to be ThiK-independent, its transport is 287 
strongly influenced by ABC transporter integrity. At the same time, effects of compound 16 in 288 
wild type cells are not as prominent as those observed for TT. Compound 7 however, does not 289 
only reveal strong reporter gene repression, but this effect is even independent of ThiK or ThiP 290 
presence. Hence, future compound designs should take characteristics of compound 7 into 291 
account in order to provide novel chemical entities whose in vivo activity does not depend on the 292 
individual enzyme repertoire of the target cell. Also, investigating potential routes of metabolism 293 
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of phosphate-mimicking compounds may unveil further information and support the generation 294 
of even more precise riboswitch‐regulating compounds. 295 
The distinct efficiencies of TT-derivatives and PT in repression of gene expression, further point 296 
at possible secondary effects of the employed metabolite analogs. These side effects may rely on 297 
interactions with enzymes involved in thiamine pyrophosphate metabolic pathways. Indeed it has 298 
been shown that triazole-derivatives of thiamine pyrophosphate inhibit enzymes involved in the 299 
biosynthesis of TPP in vitro (Erixon, Dabalos et al. 2007).  300 
Others have shown that analogs with a positively charged middle ring bind much better to the 301 
thiM riboswitch than ones with a neutral ring at this position (Chen, Cressina et al. 2012). It was 302 
suggested that this is due to the electron drawing effect of the middle ring, which enhances the 303 
binding of the pyrimidine moiety to the cognate part of the aptamer domain. The reporter gene 304 
assay presented herein however suggests that in vitro binding does not always necessarily 305 
correlate with in vivo riboswitch regulation. Even though TT does not contain a charged middle 306 
ring, it induces reporter gene repression more efficiently than PT. Moreover, our study shows that 307 
riboswitch regulation by artificial activators is dependent on the individual set of metabolic 308 
enzymes present in the organism.  309 
Since TT (1) is active in E. coli and reveals superior activity when compared to pyrithiamine it 310 
represents a very promising starting point for developing novel antibacterial compounds that 311 
target TPP-riboswitches. Furthermore, our study shows that even being very similar from a 312 
structural point of view, TT and PT engage diverse endogenous mechanisms to attain activity. 313 
These findings are of importance for the design and understanding of compounds that require 314 
intracellular activation to achieve an effective repression of gene expression.   315 
 316 
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Table 1: IC50-values of thiamine, pyrithiamine and compound 1-5 for inhibition of reporter gene 323 
expression in DH5αZ1 cells are listed. Means and 95% confidence intervals of at least three independent 324 
experiments, measured in duplicates, are shown. n. a. = not applicable; where data points could not be 325 
fitted to a dose-response curve. TT: Triazolethiamine; PT: Pyrithiamine 326 
Compound   IC50 [µM] (DH5αZ1) 95% Confidence Interval 
thiamine 0.015 0.012 to 0.019 
1 (TT) 8.4 4.6 to 15.6 
2 43.3 13.4 to 140 
3 n. a.  n. a.  
4 n. a.  n. a.  
5 22.9 12.1 to 43.4 
PT n. a.  n. a.  
 327 
Table 2: IC50-values of thiamine for inhibition of reporter gene expression in E. coli containing the 328 
indicated deletion of a non-essential thiamine biosynthesis gene are shown as mean and 95% confidence 329 
interval of at least three independent experiments, measured in duplicates. n. a. = not applicable, where 330 
data points could not be fitted to a dose-response curve. Respective curves are shown in Supplementary 331 
Figures 9 and 10. 332 
Strain   IC50 [µM] 95% Confidence 
Interval 
BW25113 (wt) 0.032 0.022 to 0.047 
ΔthiP 0.93 0.74 to 1.2 
ΔthiQ 1.5 1.0 to 2.1 
ΔtbpA 1.3 0.97 to 1.7 
ΔthiI 0.027 0.018 to 0.039 
ΔthiK n. a. n. a. 
ΔsufS 0.025 0.018 to 0.036 
ΔthiD 0.019 0.012 to 0.030 
ΔthiM 0.016 0.010 to 0.026 
ΔiscS n. a. n. a. 
ΔthiH 0.028 0.021 to 0.037 
ΔthiS 0.033 0.018 to 0.061 
ΔthiF 0.009 0.0062 to 0.013 
ΔthiE 0.071 0.045 to 0.11 
ΔthiC 0.023 0.015 to 0.035 
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ΔthiG 0.0091 0.0054 to 0.015 
 333 
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Figure and Scheme Legends 403 
Figure 1: (A) Secondary structure of the aptamer domain of the E. coli thiM riboswitch and the 404 
non-binding thiM riboswitch variant (thiM-Mu), whose alterations in P2 are shown in green 405 
(Mayer, Raddatz et al. 2007). (B) Schematic drawing of plasmid constructs and screening set-up 406 
employed for evaluating effects of thiamine analogs (compounds) in DH5αZ1 cells or Keio 407 
collection strains. When thiamine is added, it is taken up by the bacteria and converted to 408 
thiamine pyrophosphate, which then acts on the thiM riboswitch causing a repression of reporter 409 
gene expression. Levels of the reporter gene β-galactosidase are assayed by cell lysis and reaction 410 
with ortho-nitrophenyl β-galactoside (ONPG) (see methods for detailed procedure). 411 
Figure 2: (A) Chemical structures of thiamine (T), pyrithiamine (PT) and compounds 1-6 that 412 
were assayed for influence on thiM riboswitch-dependent reporter gene expression and bacterial 413 
growth inhibition. (B) Relative β-galactosidase expression in the presence of either thiamine [20 414 
µM] or compounds 1-6 and pyrithiamine (PT) [500 µM] in E. coli DH5αZ1 pRS414.2 thiM wt. 415 
Relative β-galactosidase expression in the presence of either thiamine [20 µM] or compounds 1-5 416 
and pyrithiamine (PT) [500 µM] E. coli DH5αZ1 pRS414.2 thiM-Mu (C). As compound 6 did 417 
not show significant effects in primary screenings (B) it was not used for further investigations 418 
(C). Reporter gene activity is shown in relation to maximum β-galactosidase expression in 419 
DH5αZ1 bacteria (no addition of thiamine, black bars) and addition of 500µM thiamine yield 420 
maximal reporter gene repression (dark grey bars). 421 
Scheme 1: Biosynthesis of TPP in E. coli is accomplished by the separate synthesis of the 422 
pyrimidine and thiazole moiety, which are finally coupled and phosphorylated to form TPP 423 
(Begley, Downs et al. 1999). The biosynthesis of the pyrimidine part of thiamine starts with an 424 
intermediate of the purine biosynthesis pathway, namely aminoimidazole ribotide (AIR). The 425 
thiamine biosynthesis protein ThiC whose exact function remains to be elucidated, converts AIR 426 
to hydroxymethylpyrimidine-phosphate (HMP-P), which is subsequently phosphorylated by the 427 
bifunctional HMP/ HMP-P kinase ThiD to yield hydroxymethyl-pyrimidine pyrophosphate 428 
(HMP-PP). The thiazole moiety of thiamine is derived from tyrosine, cysteine and 1-deoxy-D- 429 
xylulose phosphate (DXP). In a yet unresolved chain of reactions featuring thiF, thiS, thiG, thiH 430 
and thiI gene products, hydroxyethyl-thiazole phosphate (HET-P) is formed. HMP-PP and HET-P 431 
are joined by one enzymatic step mediated by the ThiE protein, followed by phosphorylation of 432 
the formed TMP by ThiL to create TPP. Three distinct kinases, ThiM, ThiD, and ThiK, are 433 
involved in the salvage of HET, HMP, and thiamine, respectively, from the culture medium. 434 
Thiamine, thiamine phosphate, and thiamine pyrophosphate are actively transported in enteric 435 
bacteria using the ABC transport system ThiBPQ (Webb, Claas et al. 1998). At present, no other 436 
distinct thiamine transporters, neither HET nor HMP transport systems, have been identified in 437 
bacteria (Rodionov, Vitreschak et al. 2002). Essential genes are colored red, gray genes are not 438 
validated in E. coli. 439 
Figure 3: Effect of thiamine (A), triazolethiamine (B) or pyrithiamine (C) on reporter gene 440 
expression in BW25113 (black bars) and BW25113 strains with the indicated deletion. Minimal 441 
medium was supplemented with 500µM of thiamine (T), TT or PT. magenta bars: thiamine 442 
transport genes; green bars: phosphorylation enzymes; grey bars: genes involved in thiazole 443 
formation. 444 
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Figure 4: Chemical formulas of triazole thiamine analogs with phosphate mimicking groups (A). 445 
Relative β-galactosidase expression in the presence of thiamine or compound [500µM] in 446 
DH5αZ1 cells is shown (B). 447 
 448 
Figure 5:  Effect of thiamine, TT, PT and phosphate mimics 7 and 16 on β-galactosidase 449 
expression in E. coli strains ΔthiK (A), BW25113 (B) and ΔthiP (C). Minimal medium (refer to 450 
experimental procedures for details) was supplemented with 500µM of analyte. Compound 16 451 
was dissolved to a stock solution of 100mM in 100% DMSO, assay controls also contained a final 452 
DMSO concentration of 1%.  453 
 454 
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